1. Signaling Pathways
  2. NF-κB
  3. NF-κB

NF-κB (核因子κB)

Nuclear factor-κB; Nuclear factor-kappaB

NF-κB(活化 B 细胞的核因子 κ 轻链增强子)是一种控制 DNA 转录的蛋白质复合物。NF-κB 存在于几乎所有动物细胞类型中,并参与细胞对压力、细胞因子、自由基、紫外线照射、氧化 LDL 以及细菌或病毒抗原等刺激的反应。NF-κB 在调节对感染的免疫反应中起着关键作用。NF-κB 的错误调节与癌症、炎症和自身免疫性疾病、感染性休克、病毒感染和免疫发育不当有关。NF-κB 还与突触可塑性和记忆过程有关。哺乳动物 NF-κB 家族中有五种蛋白质:NF-κB1、NF-κB2、RelA、RelB、c-Rel。

NF-κB (Nuclear factor kappa-light-chain-enhancer of activated B cells) is a protein complex that controls transcription of DNA. NF-κB is found in almost all animal cell types and is involved in cellular responses to stimuli such as stress, cytokines, free radicals, ultraviolet irradiation, oxidized LDL, and bacterial or viral antigens. NF-κB plays a key role in regulating the immune response to infection. Incorrect regulation of NF-κB has been linked to cancer, inflammatory, and autoimmune diseases, septic shock, viral infection, and improper immune development. NF-κB has also been implicated in processes of synaptic plasticity and memory. There are five proteins in the mammalian NF-κB family: NF-κB1, NF-κB2, RelA, RelB, c-Rel.

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-N3807
    Enniatin B1

    恩镰孢菌素 B1

    Inhibitor 99.34%
    Enniatin B1 是一种镰刀菌毒素。在大鼠肝微粒体酶实验中,Enniatin B1 抑制酰基辅酶 A:胆固醇酰基转移酶 (ACAT) 活性,IC50 为 73 μM。Enniatin B1 能透过血脑屏障。Enniatin B1 降低 ERK (p44/p42) 活化。Enniatin B1 抑制 TNF-α 诱导的 NF-κB激活。
    Enniatin B1
  • HY-N3063
    Pimaric acid Inhibitor 98.76%
    Pimaric acid 是一种树脂酸,具有抗癌作用,发现于海松 (A. cordata) 和各种松树中。Pimaric acid 在人卵巢癌细胞中通过内质网应激、caspase 依赖性凋亡、细胞周期阻滞和细胞迁移抑制发挥抗癌作用。Pimaric acid 降低 TNF-α 刺激的人主动脉平滑肌细胞 (HASMCs) 中基质金属蛋白酶-9 (MMP-9) 的 mRNA 表达、蛋白水平和启动子活性。
    Pimaric acid
  • HY-111237
    Butyrolactone I Inhibitor 99.80%
    Butyrolactone I 是口服活性的 CDK1 的 ATP 竞争性抑制剂。Butyrolactone I 抑制 NF-κBcdc2 激酶、BaxROS 产生,调节 PERK/CHOP。Butyrolactone I 可减轻热应激引起的凋亡 (Apoptosis)。Butyrolactone I 具有抗炎和肠道保护作用。Butyrolactone I 对非小细胞肺癌、小细胞肺癌、前列腺癌和白血病具有抗肿瘤作用。Butyrolactone I 可用于 NASH 研究。
    Butyrolactone I
  • HY-137976
    Penehyclidine hydrochloride

    盐酸戊乙奎醚

    Activator 99.2%
    Penehyclidine (Penequinine) hydrochloride 是一种抗胆碱能活性分子,选择性的 M1M3 受体拮抗剂。Penehyclidine hydrochloride 可激活肺组织中的 NF-kβ 并抑制炎症因子的释放。Penehyclidine hydrochloride 可减轻慢性阻塞性肺病 (COPD) 大鼠机械通气时的肺部炎症反应。
    Penehyclidine hydrochloride
  • HY-144765
    NF-κB-IN-4 Inhibitor 98.51%
    NF-κB-IN-4 (化合物 17) 是一种有效的可透过血脑屏障的 NF-κB 通路抑制剂。NF-κB-IN-4 表现出潜在的低毒性抗神经炎症活性。NF-κB-IN-4 可阻断 IκBα 的激活和磷酸化,降低 NLRP3 的表达,从而抑制 NF-κB 的激活。NF-κB-IN-4 可用于神经炎症相关疾病的研究。
    NF-κB-IN-4
  • HY-N7931
    Regaloside A

    王百合苷A

    Inhibitor 99.64%
    Regaloside A 是一种苯丙烷,在 160 ppm 时显示出 58.0% 的显着 DPPH 自由基清除活性。Regaloside A 具有抗炎活性。
    Regaloside A
  • HY-111024
    2,2,5,7,8-Pentamethyl-6-Chromanol Inhibitor 99.30%
    2,2,5,7,8-Pentamethyl-6-Chromanol (PMC) 是维生素 E (α-tocopherol) 的抗氧化部分。2,2,5,7,8-Pentamethyl-6-Chromanol 具有有效的雄激素受体 (androgen receptor) 信号调节和抗前列腺癌细胞系的抗癌活性。
    2,2,5,7,8-Pentamethyl-6-Chromanol
  • HY-N0168A
    (Rac)-Hesperetin 99.28%
    (Rac)-Hesperetin 是 Hesperetin 的外消旋体。Hesperetin 是一种天然黄烷酮,存在于柑橘类水果中,是一种强效且具有口服活性的广谱人类 UGT 活性抑制剂。Hesperetin 通过激活 p38 MAPK 诱导细胞凋亡。Hesperetin 具有多种生物活性,包括抗氧化、抗炎和抗癌。Hesperetin 可诱导细胞周期停滞于 G2/M 期。Hesperetin 可以降低 Bcl-2 并增强 BaxM。Hesperetin 通过抑制 NF-κB 受体诱导细胞凋亡 (apoptosis)。
    (Rac)-Hesperetin
  • HY-100977
    Dimethoxycurcumin Inhibitor 98.40%
    Dimethoxycurcumin 是 curcumin 的衍生物,具有抗炎和抗氧化活性。
    Dimethoxycurcumin
  • HY-N8307
    Syringaresinol

    丁香脂素

    Inhibitor 99.15%
    Syringaresinol 是一种具有抗炎活性的木脂素类植物化学物质。Syringaresinol 抑制 IL-1β 激活的小鼠软骨细胞中的 NF-κBAKT 信号通路。Syringaresinol 增加 HUVECs 中 AMPKeNOS 的磷酸化以及细胞内 Ca2+ 水平。Syringaresinol 减缓内侧半月板失稳术 (DMM) 诱导的骨关节炎小鼠的骨关节炎进展。Syringaresinol 可用于骨关节炎 (OA) 研究。
    Syringaresinol
  • HY-N6029
    Dehydroevodiamine hydrochloride

    盐酸去氢吴茱萸碱

    99.93%
    Dehydroevodiamine hydrochloride 从吴茱萸叶中分离得到。
    Dehydroevodiamine hydrochloride
  • HY-107744
    Nalmefene Inhibitor 99.70%
    Nalmefene 是一种能透过血脑屏障的阿片受体调节剂,是 MORDOR 拮抗剂,也是 KOR 部分激动剂。Nalmefene 具有抗炎、神经保护的活性。Nalmefene 可用于减少酒精依赖性疾病的研究。
    Nalmefene
  • HY-121246
    Fluorofenidone Inhibitor 99.78%
    Fluorofenidone (AKF-PD) 是一种具有口服活性的化合物,具有抗纤维化、抗氧化和抗炎的药理作用。Fluorofenidone 下调 ACSL4 的表达,上调 GPX4 的表达,并抑制 NF-κB 信号通路以减轻炎症和纤维化。Fluorofenidone 通过抑制小鼠肝脏的 Erk/-Egr-1 信号通路和 Tgfβ1/Smad 通路改善胆汁淤积和纤维化。Fluorofenidone 在小鼠中对慢性肺损伤表现出保护作用。Fluorofenidone 可用于慢性阻塞性肺疾病 (COPD),肺间质纤维化 (PIF) 和非小细胞肺癌 (NSCLC) 的研究。
    Fluorofenidone
  • HY-112569
    MAT2A inhibitor 2 Inhibitor 99.71%
    MAT2A inhibitor 2 是一种具有口服活性的甲硫氨酸腺苷转移酶 2A (MAT2A) 的抑制剂。MAT2A inhibitor 2 可用于骨质疏松症的研究。
    MAT2A inhibitor 2
  • HY-107352
    Fosfenopril

    福辛普利拉EP杂质A)

    Inhibitor 99.85%
    Fosfenopril (Fosinoprilat) 是一种有效的血管紧张素转换酶 (ACE) 抑制剂。Fosfenopril 通过抑制单核细胞中 TLR4/NF-κB 信号通路缓解脂多糖 (LPS) 诱导的炎症反应。
    Fosfenopril
  • HY-N0191R
    Andrographolide (Standard)

    穿心莲内酯 (Standard)

    Inhibitor
    Andrographolide (Standard) 是 Andrographolide 的分析标准品。本产品用于研究及分析应用。Andrographolide 是一种 NF-κB 抑制剂,通过共价修饰内皮细胞中 p50 的半胱氨酸残基而抑制 NF-κB 活化,而不影响 IκBα 降解或 p50/p65 核易位。Andrographolide 具有抗病毒作用。
    Andrographolide (Standard)
  • HY-W013507
    (rac)-Methyl jasmonate

    (rac)-茉莉酮酸甲酯

    Inhibitor 99.28%
    (rac)-Methyl jasmonate 是 Methyl jasmonate (HY-135663) 的消旋体。Methyl jasmonate 是一种植物激素,通过茉莉酸信号通路调节植物在生物胁迫和生物逆境下的防御反应。Methyl jasmonate 抑制 NF-κB 信号通路的激活。Methyl jasmonate 可以促进线粒体活性氧(ROS)的产生,同时还能清除自由基,减轻氧化应激。Methyl jasmonate 具有抗炎、抗肿瘤、抗惊厥、镇痛和镇静等活性。
    (rac)-Methyl jasmonate
  • HY-N9396
    Nasunin Inhibitor 99.30%
    Nasunin 是一种抗氧化花青素、具有抗血管生成活性。
    Nasunin
  • HY-W041489
    Chelidonic acid

    白屈菜酸

    Inhibitor 99.91%
    Chelidonic acid 是从 Chelidonium majus L. 中分到的酸类物质,为一种抗菌剂。Chelidonic acid 具有抗炎作用,可能通过抑制 NF-κBcaspase-1 来降低 IL-6 的产生。Chelidonic acid 为 glutamate decarboxylase 抑制剂,Ki 值为 1.2 μM。
    Chelidonic acid
  • HY-19416
    AEOL-10150 pentachloride Modulator 98.0%
    AEOL-10150 pentachloride 是一种金属卟啉催化抗氧剂,也是一种超氧化物歧化酶模拟物。AEOL-10150 pentachloride 清除活性氧 (ROS) 和活性氮 (RNS)、调节 NF-κB 信号通路。AEOL-10150 pentachloride 具有强效的抗氧化和抗炎活性。AEOL-10150 pentachloride 有效减轻辐射、化学试剂 (如 CEES (HY-W199190)) 造成的组织损害。AEOL-10150 pentachloride 协同放疗对前列腺肿瘤发挥抗癌作用。
    AEOL-10150 pentachloride
目录号 产品名 / 同用名 应用 反应物种

NF-κB transcription factors are critical regulators of immunity, stress responses, apoptosis and differentiation. In mammals, there are five members of the transcription factor NF-κB family: RELA (p65), RELB and c-REL, and the precursor proteins NF-κB1 (p105) and NF-κB2 (p100), which are processed into p50 and p52, respectively. NF-κB transcription factors bind as dimers to κB sites in promoters and enhancers of a variety of genes and induce or repress transcription. NF-κB activation occurs via two major signaling pathways: the canonical and the non-canonical NF-κB signaling pathways[1]

 

The canonical NF-κB pathway is triggered by signals from a large variety of immune receptors, such as TNFR, TLR, and IL-1R, which activate TAK1. TAK1 then activates IκB kinase (IKK) complex, composed of catalytic (IKKα and IKKβ) and regulatory (NEMO) subunits, via phosphorylation of IKKβ. Upon stimulation, the IKK complex, largely through IKKβ, phosphorylates members of the inhibitor of κB (IκB) family, such as IκBα and the IκB-like molecule p105, which sequester NF-κB members in the cytoplasm. IκBα associates with dimers of p50 and members of the REL family (RELA or c-REL), whereas p105 associates with p50 or REL (RELA or c-REL). Upon phosphorylation by IKK, IκBα and p105 are degradated in the proteasome, resulting in the nuclear translocation of canonical NF-κB family members, which bind to specific DNA elements, in the form of various dimeric complexes, including RELA-p50, c-REL-p50, and p50-p50. Atypical, IKK-independent pathways of NF-κB induction also provide mechanisms to integrate parallel signaling pathways to increase NF-κB activity, such as hypoxia, UV and genotoxic stress.

 

The non-canonical NF-κB pathway is induced by certain TNF superfamily members, such as CD40L, BAFF and lymphotoxin-β (LT-β), which stimulates the recruitment of TRAF2, TRAF3, cIAP1/2 to the receptor complex. Activated cIAP mediates K48 ubiquitylation and proteasomal degradation of TRAF3, resulting in stabilization and accumulation of the NFκB-inducing kinase (NIK). NIK phosphorylates and activates IKKα, which in turn phosphorylates p100, triggering p100 processing, and leading to the generation of p52 and the nuclear translocation of p52 and RELB[2][3].

 

Reference:

[1]. Oeckinghaus A, et al. The NF-kappaB family of transcription factors and its regulation.Cold Spring Harb Perspect Biol. 2009 Oct;1(4):a000034. 
[2]. Taniguchi K, et al. NF-κB, inflammation, immunity and cancer: coming of age. Nat Rev Immunol. 2018 May;18(5):309-324.
[3]. Perkins ND,et al. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol. 2007 Jan;8(1):49-62.

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.